LCTX

LCTX Change in Working Capital

-$3.97MTTM · USD

Period ending:

LCTX FY Change in Working CapitalUSD
LCTX FY Change in Working Capital1992-06-30: $100.00K1993-06-30: -$100.00K1994-06-30: -$100.00K1995-06-30: $400.00K1996-06-30: -$400.00K1998-06-30: $1.50M1998-12-31: $100.00K1999-12-31: $440.37K2000-12-31: -$251.13K2001-12-31: -$38.53K2002-12-31: $74.34K2003-12-31: $126.00K2004-12-31: $353.54K2005-12-31: $485.57K2006-12-31: $269.44K2007-12-31: $106.96K2008-12-31: $1.44M2009-12-31: -$306.10K2010-12-31: -$447.76K2011-12-31: $26.12K2012-12-31: $468.01K2013-12-31: $2.73M2014-12-31: -$827.05K2015-12-31: $3.31M2016-12-31: -$741.00K2017-12-31: $2.48M2018-12-31: $638.00K2019-12-31: -$1.96M2020-12-31: $1.37M2021-12-31: $21.11M2022-12-31: $18.67M2023-12-31: -$10.80M2024-12-31: -$8.77M2025-12-31: -$4.11M$21.11M-$10.80M
1992-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LCTX change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 34 observations from Jun 30, 1992 to Dec 31, 2025.

Lineage Cell Therapeutics, Inc. Common Stock Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-4,110,000
-8,766,000
-10,804,000
18,669,000
21,110,000
1,373,000
-1,956,000
638,000
2,478,000
-741,000
3,305,000
-827,050
2,725,802
468,013
26,122
-447,763
-306,100
1,442,426
106,959
269,435
485,573
353,543
126,002
74,336
-38,534
-251,127
440,369
100,000
1,500,000
-400,000
400,000
-100,000
-100,000
100,000

Compare change in working capital

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.